NFKB1 and diffuse large B-cell lymphoma: Whereas dual inhibition of PI3Kα/δ has been shown to mainly affect the NF-κB-dependent ABC DLBCL subtype, we are unable to correlate the efficacy of PI3Kβ/δ inhibition with any known molecular DLBCL subtype [12].